Logo
i

indee labs (YC W17)

5 employees

Indee Labs is unlocking gene-modified cell therapy for the masses with scalable hardware for gene delivery.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Gene Therapy
T Cell Manufacturing
Cellular Engineering
Gene Editing
Genetic Engineering
Immunotherapy
Non-Viral Delivery
Transfection
Intracellular Delivery
Microfluidics
Medical Devices
T Cell Immunotherapy
Genetics
Manufacturing
Cell-derived Gene Therapy

Date founded

2015

Funding rounds raised

Total raised

$2.6M

from 12 investors over 12 rounds

i

indee labs (YC W17) raised undisclosed on June 6, 2023

Investors: BioTools Innovator

i

indee labs (YC W17) raised undisclosed on September 23, 2021

Investors: IndieBio and SOSV - The Accelerator VC

i

indee labs (YC W17) raised undisclosed on November 2, 2020

Investors: Endpoint Ventures

i

indee labs (YC W17) raised undisclosed on August 24, 2020

Investors: National Institute of Allergy and Infectious Diseases (NIAID)

i

indee labs (YC W17) raised $2.6M on May 17, 2018

Investors: Founders Fund and Main Sequence Ventures

i

indee labs (YC W17) raised $692K on April 18, 2018

Investors: MTPConnect

i

indee labs (YC W17) raised $1.3M on July 3, 2017

Investors: IndieBio and SOSV - The Accelerator VC

i

indee labs (YC W17) raised $120K on March 20, 2017

Investors: Y Combinator and Bossa Nova Investimentos

FAQ